Reference number : 172-2018-2019-Q2-912341, amendment number : 1, agreement type : C, recipient legal name : Novelogics Biotechnology Inc., recipient country : CA, recipient province : BC, recipient city : Port Coquitlam|Port Coquitlam, recipient postal code : V3C 6E8, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : Validation Studies on Immune Modulating Therapeutic Antibodies, agreement title french : Études de validation sur des anticorps thérapeutiques à modulation immunitaire, agreement number : 912341, agreement value : 160560.0, agreement start date : 2018-09-01, agreement end date : 2019-07-31, description english : Novelogics Biotechnology Inc. is developing an innovative antibody immunotherapy treatment for use in cancer patients that functions to restore a key component of the immune system, and which is expected to be less toxic than many traditional cancer drugs while improving patient outcomes when used with other therapies., description french : Études de validation sur des anticorps thérapeutiques à modulation immunitaire, expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days., additional information french : Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de  61 jours., owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada